octob
april
hospitalis
patient
year
includ
cap
diagnos
within
hour
admiss
cap
defin
radiolog
evid
infiltr
chest
xray
criteria
cough
purul
sputum
temperatur
c
abnorm
chest
auscult
white
blood
cell
count
l
posit
cultur
blood
pleural
fluid
subject
exclud
receiv
parenter
antibiot
inclus
hospitalis
within
four
week
admiss
sever
immunocompromis
hiv
infect
chemotherapi
neutropenia
steroid
treatment
mgday
two
week
termin
stage
malign
evid
caus
abnorm
xray
patient
assess
upon
admiss
follow
daili
hospitalis
accord
standardis
protocol
age
gender
cigarett
alcohol
use
clinic
present
record
admiss
chest
xray
assess
radiologist
incharg
later
reassess
develop
standardis
xray
descript
complet
blood
cellcount
blood
chemistri
bloodga
analysi
perform
admiss
underli
diseas
assess
clinic
laboratori
radiolog
data
sever
score
determin
use
pneumonia
sever
index
psi
outcom
assess
mortal
manag
patient
left
discret
physician
charg
sputum
throat
swab
blood
pair
sera
interv
urin
sent
clinic
microbiolog
laboratori
dr
kariadi
hospit
semarang
gramstain
smear
evalu
assess
sputum
qualiti
help
cultur
interpret
ziehlneelsen
stain
done
screen
acid
fast
bacilli
blood
cultur
inocul
four
bactec
bottl
bectondickinson
rochest
uk
per
patient
sputum
sampl
inocul
blood
agar
chocol
agar
chocol
agar
gentamicin
mgl
macconkey
agar
oxoid
basingstok
uk
crystal
violet
colistin
broth
cvcb
ashdown
agar
use
burkholderia
pseudomallei
isol
bacteria
isol
initi
cultur
sputa
throat
swab
sera
urin
store
c
transport
rotterdam
analys
streptococcu
pneumonia
identifi
optochin
disk
oxoid
case
doubt
dna
probe
accuprob
san
diego
usa
gramneg
bacilli
gnb
identifi
use
system
rieux
letoil
franc
acinetobact
baumannii
identifi
use
pcr
bla
moraxella
catarrhali
confirm
use
tributyrin
test
rosco
diagnosticstaastrup
denmark
xv
factor
becton
dickinson
compani
spark
usa
use
haemophilu
influenza
identif
slidex
staph
plu
latex
agglutin
rieux
use
staphylococcu
aureu
identif
ziehlneelsen
posit
sputa
cultur
mgit
media
bectondickinson
rochest
uk
confirm
pcr
antimicrobi
suscept
test
perform
disk
diffus
pneumonia
aureu
gnb
etest
catarrhali
extendedspectrum
blactamas
esbl
product
suspect
isol
analyz
cefotaximeclavulan
ceftazidimeclavulan
etest
rieux
refer
strain
atcc
use
control
clsi
guidelin
appli
serolog
test
perform
elisa
chlamydia
pneumonia
medac
diagnostika
germani
mycoplasma
pneumonia
virionserion
rzburg
germani
legionella
pneumophila
wampol
laboratori
princeton
usa
leptospira
serolog
perform
use
microscop
agglutin
test
mat
elisa
royal
tropic
institut
kit
amsterdam
netherland
patient
clinic
syndrom
compat
leptospirosi
elisa
respiratori
virus
virionserion
perform
laboratori
virosci
erasmu
mc
realtim
pcr
rtpcr
done
sputum
throat
swab
c
pneumonia
l
pneumophila
describ
elsewher
rtpcr
pneumonia
rhinoviru
human
corona
viru
hcov
influenza
b
viru
human
metapneumoviru
hmpv
rsv
b
parainfluenza
viru
adenoviru
bocaviru
perform
throat
swab
valid
pcr
procedur
pcr
leptospira
chlamydia
psittaci
done
describ
elsewher
pcr
mycobacterium
tuberculosi
perform
erasmu
mc
urinari
antigen
test
binaxnow
portland
usa
perform
detect
pneumonia
l
pneumophila
antigen
sputum
cultur
consid
posit
sputum
qualiti
good
leukocyt
epithelialcel
ratio
leukocyt
count
power
field
lpf
epithelialcel
count
bacteria
grow
predominantli
agar
compat
sputum
microscopi
blood
cultur
consid
posit
bacteria
present
bottl
establish
pathogen
bottl
speci
serolog
consid
posit
fourfold
titer
increas
immunoglobulin
class
influenza
b
sinc
reinfect
one
year
unlik
singl
sera
posit
iga
neg
igg
first
week
ill
also
consid
posit
immunoglobulin
class
measur
igm
iga
igg
c
pneumonia
total
immunoglobulin
l
pneumophila
iga
igg
respiratori
virus
igm
igg
pneumonia
igm
total
immunogloblin
leptospira
rtpcr
consid
posit
ct
valu
pneumonia
leptospira
pathogen
posit
influenza
pcr
follow
anoth
pcr
distinguish
influenza
virus
visibl
reaction
urinari
antigen
test
consid
posit
instruct
manufactur
patient
comprehens
review
clinic
radiolog
laboratori
data
perform
panel
involv
pulmonologist
infecti
diseas
specialist
radiologist
clinic
microbiologist
draw
final
conclus
etiolog
cap
etiolog
consid
establish
microbiolog
test
result
compat
clinic
present
radiolog
chisquar
fisher
exact
test
appropri
perform
use
spss
spss
inc
chicago
usa
kaplanmei
method
logrank
test
use
perform
surviv
analysi
p
valu
consid
signific
studi
approv
ethic
committe
faculti
medicin
diponegoro
universitydr
kariadi
hospit
written
inform
consent
obtain
patient
guardian
patient
enrol
hospitalis
dr
kariadi
hospit
semarang
municip
hospit
eight
patient
exclud
nonconfirm
cap
diagnosi
acut
respiratori
distress
syndrom
patient
urosepsi
patient
infiltr
xray
reassess
patient
preced
parenter
antibiot
patient
patient
age
rang
year
age
year
patient
underli
diseas
two
underli
diseas
sever
pneumonia
psi
ivv
found
patient
chest
xray
show
bronchopneumonia
tabl
patient
receiv
oral
antibiot
prior
hospit
admiss
unsur
whether
receiv
antibiot
thirti
eight
patient
complet
set
test
specimen
tabl
data
miss
underli
diseas
sever
mortal
onehundr
fifti
respiratori
pathogen
identifi
patient
microbiolog
method
pathogen
identifi
describ
tabl
final
conclus
regard
cap
etiolog
summaris
tabl
singl
caus
agent
found
patient
virus
bacteria
polymicrobi
infect
found
patient
includ
viral
infect
superimpos
bacteri
infect
tuberculosi
superimpos
secondari
infect
mixedinfect
multipl
virus
multipl
bacteria
combin
viru
es
bacteria
tabl
seventi
virus
identifi
patient
influenza
commonest
identifi
patient
pcr
detect
case
serolog
detect
case
tabl
influenza
virus
patient
singl
pathogen
found
tabl
eight
patient
pathogen
also
involv
tabl
togeth
influenza
b
virus
caus
case
cap
cohort
either
singl
copathogen
second
commonest
viru
rhinoviru
case
detect
pcr
six
patient
viru
singl
pathogen
seven
copathogen
parainfluenza
viru
third
commonest
viru
detect
patient
mostli
pcr
five
episod
singl
pathogen
six
copathogen
virus
found
hcov
adenoviru
hmpv
rsv
copathogen
detect
pcr
eighti
bacteria
found
patient
klebsiella
pneumonia
pneumonia
frequent
diagnos
k
pneumonia
isol
patient
sputum
cultur
blood
sputum
cultur
pneumonia
diagnos
patient
mostli
urinari
antigen
test
tabl
c
pneumonia
tuberculosi
third
commonest
bacteri
speci
identifi
diagnos
patient
gnb
enterobact
cloaca
klebsiella
oxytoca
achromobact
xylosoxidan
burkholderia
cepacia
identifi
patient
isol
sputum
cultur
burkholderia
pseudomallei
found
blood
cultur
posit
patient
combin
pathogen
patient
present
tabl
frequent
combin
pathogen
k
pneumonia
pneumonia
adenoviru
k
pneumonia
influenza
coronaviru
pneumonia
etiolog
cap
could
elucid
patient
pathogen
detect
predict
relat
avail
diagnost
specimen
case
unknown
etiolog
one
patient
complet
laboratori
specimen
test
result
neg
incomplet
laboratori
specimen
posit
result
one
mani
posit
serolog
result
conclus
could
drawn
patient
sever
diseas
psi
class
ivv
less
like
receiv
etiolog
diagnosi
compar
nonsever
diseas
psi
class
iiii
one
isol
k
pneumonia
esblproduc
other
suscept
antibiot
except
piperacillin
resist
nitrofurantoin
resist
four
regrow
pneumonia
suscept
penicillin
erythromycin
vancomycin
one
intermedi
resist
cotrimoxazol
three
resist
tetracyclin
signific
differ
underli
diseas
psi
class
length
stay
mortal
among
patient
singl
viral
singl
bacteri
mix
viralbacteri
infect
p
patient
mixedvir
mixedbacteri
infect
analys
due
small
number
overal
mortal
rate
high
significantli
associ
sever
diseas
p
mortal
rate
rang
psi
class
patient
psi
class
v
patient
interestingli
surviv
analysi
show
significantli
lower
surviv
rate
cap
patient
unknown
etiolog
figur
earli
death
hour
hospit
happen
patient
mortal
associ
respiratori
failur
irrevers
septic
shock
earli
deceas
patient
subject
delay
access
icu
care
limit
avail
servic
late
death
hour
hospit
occur
patient
mortal
associ
worsen
condit
cap
patient
underli
diseas
patient
despit
clinic
improv
patient
mortal
die
discharg
hospit
inhom
recoveri
within
day
admiss
circumst
latter
death
remain
unknown
first
cap
etiolog
studi
conduct
indonesia
appli
full
rang
microbiolog
test
influenza
virus
k
pneumonia
pneumonia
commonest
agent
cap
region
world
viral
infect
surprisingli
common
either
singl
combin
etiolog
pcr
instrument
detect
respiratori
virus
recent
report
thailand
found
virus
hospitalis
adult
cap
patient
northern
thailand
adult
cap
patient
admit
pneumonia
detail
see
tabl
surveil
two
provinc
incid
influenza
infect
hospitalis
cap
sever
cap
use
pcr
may
thu
enhanc
appropri
use
antimicrobi
agent
cap
studi
southeast
asia
far
attempt
diagnos
virus
k
pneumonia
gnb
frequent
observ
studi
similar
report
southeast
asian
countri
differ
europ
north
america
australia
high
preval
k
pneumonia
gnb
might
part
explain
common
carriag
bacteri
speci
nasopharynx
healthi
individu
area
tropic
climat
higher
temperatur
humid
semarang
may
increas
incid
gnb
infect
condit
promot
growth
virul
gnb
pneumonia
infect
detect
patient
mostli
urinari
antigen
test
cultur
frequent
fail
grow
speci
possibl
due
common
use
antibiot
commun
underlin
import
altern
method
detect
pneumococci
pcr
urinari
antigen
test
howev
posit
find
latter
test
interpret
care
particularli
patient
copd
previou
studi
southeast
asia
report
variou
number
rel
contribut
pneumonia
depend
studi
popul
laboratori
method
studi
europ
north
america
australia
consist
report
common
caus
cap
asid
climat
differ
cap
etiolog
report
studi
previou
report
might
also
relat
differ
patient
age
underli
diseas
radiolog
type
pneumonia
patient
rel
young
often
cerebrovascular
underli
diseas
often
bronchopneumonia
instead
lobar
alveolar
pneumonia
wide
spread
use
influenza
vaccin
part
world
may
help
explain
differ
incid
influenza
cap
taken
togeth
differ
impli
guidelin
cap
manag
constru
implement
europ
north
america
australia
might
directli
applic
indonesia
cap
studi
distinguish
definit
probabl
etiolog
base
microbiolog
result
use
distinct
instead
interpret
microbiolog
clinic
radiolog
find
multidisciplinari
discuss
make
final
diagnosi
sinc
opinion
clinic
data
omit
extend
rang
laboratori
diagnost
appli
includ
viral
well
bacteri
fungal
pathogen
predict
increas
number
pathogen
detect
therebi
increas
chanc
find
polymicrobi
infect
found
mix
infect
sizabl
proport
cohort
patient
includ
studi
mix
infect
common
eg
viral
infect
superimpos
bacteri
infect
tuberculosi
superimpos
infect
mix
infect
eg
multipl
bacteria
multipl
virus
difficult
understand
pose
problem
discrimin
infect
carriag
bacteria
caus
cap
studi
suscept
earli
gener
antibiot
find
consist
observ
indonesia
henc
choic
antibiot
initi
empir
treatment
cap
includ
later
gener
antibiot
includ
third
gener
cephalosporin
recommend
local
guidelin
appropri
choic
consid
would
amoxicillinclavulan
acid
ampicillinsulbactam
crude
mortal
rate
high
relat
sever
diseas
howev
even
low
risk
patient
mortal
studi
still
quit
high
compar
northamerica
europ
also
studi
southeast
asian
countri
high
mortal
observ
studi
suggest
problem
patient
care
process
need
analysi
determin
poor
outcom
may
least
part
includ
delay
present
hospit
inappropri
initi
treatment
limit
access
mechan
ventil
inappropri
antibiot
therapi
underli
diseas
sever
diseas
admiss
publish
elsewher
interestingli
mortal
significantli
higher
among
patient
unknown
etiolog
find
may
explain
limit
acquir
appropri
laboratori
sampl
due
sever
diseas
time
patient
admit
rather
unfortun
sinc
patient
need
manag
base
establish
etiolog
find
impli
need
perform
diagnost
procedur
earli
without
delay
especi
patient
sever
diseas
etiolog
cap
group
establish
earli
time
manag
still
optimis
sinc
studi
perform
one
urban
area
indonesia
involv
two
hospit
find
might
repres
whole
indonesia
similar
multicent
studi
etiolog
cap
indonesia
would
need
confirm
peculiar
spectrum
etiolog
cap
indonesia
suggest
studi
multicent
cap
studi
includ
viral
etiolog
carri
indonesia
countri
region
delin
full
spectrum
etiolog
agent
cap
patient
gener
local
guidelin
manag
cap
bacteria
caus
cap
area
world
continu
present
wild
type
antibiot
suscept
profil
earli
gener
antibiot
use
initi
empir
treatment
therebi
avoid
expens
select
pressur
exert
newer
gener
antibiot
especi
third
gener
cephalosporin
carbapenem
frequent
incid
gnb
infect
requir
initi
therapi
cover
gnb
addit
pneumococcu
rapid
bacteriolog
diagnost
requir
abl
adapt
initi
therapi
includ
altern
test
detect
pneumonia
perform
diagnost
procedur
earli
without
delay
priorit
sinc
establish
etiolog
diagnosi
like
improv
clinic
outcom
